Cell-Based Therapies for Stroke: Are We There Yet?

cell therapy clinical trial clinical trial costs stem cells stroke

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2019
Historique:
received: 01 03 2019
accepted: 04 06 2019
entrez: 12 7 2019
pubmed: 12 7 2019
medline: 12 7 2019
Statut: epublish

Résumé

Stroke is the second leading cause of death and physical disability, with a global lifetime incidence rate of 1 in 6. Currently, the only FDA approved treatment for ischemic stroke is the administration of tissue plasminogen activator (tPA). Stem cell clinical trials for stroke have been underway for close to two decades, with data suggesting that cell therapies are safe, feasible, and potentially efficacious. However, clinical trials for stroke account for <1% of all stem cell trials. Nevertheless, the resources devoted to clinical research to identify new treatments for stroke is still significant (53-64 million US$, Phase 1-4). Notably, a quarter of cell therapy clinical trials for stroke have been withdrawn (15.2%) or terminated (6.8%) to date. This review discusses the bottlenecks in delivering a successful cell therapy for stroke, and the cost-to-benefit ratio necessary to justify these expensive trials. Further, this review will critically assess the currently available data from completed stroke trials, the importance of standardization in outcome reporting, and the role of industry-led research in the development of cell therapies for stroke.

Identifiants

pubmed: 31293500
doi: 10.3389/fneur.2019.00656
pmc: PMC6603096
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

656

Références

Neurology. 2000 Aug 22;55(4):565-9
pubmed: 10953194
J Neurol Sci. 2001 Aug 15;189(1-2):49-57
pubmed: 11535233
Stroke. 2002 May;33(5):1362-8
pubmed: 11988616
JAMA. 2003 Jan 22-29;289(4):454-65
pubmed: 12533125
Plast Reconstr Surg. 2003 May;111(6):1922-31
pubmed: 12711954
Brain Res. 2004 May 8;1007(1-2):1-9
pubmed: 15064130
Stroke. 2004 May;35(5):1209-15
pubmed: 15073405
J Insur Med. 2004;36(2):143-52
pubmed: 15301227
BMC Neurosci. 2004 Sep 15;5:33
pubmed: 15369599
NeuroRx. 2004 Oct;1(4):406-14
pubmed: 15717044
Stem Cells. 2005 Mar;23(3):383-91
pubmed: 15749933
Stem Cells. 2005 Mar;23(3):392-402
pubmed: 15749934
Ann Neurol. 2005 Jun;57(6):874-82
pubmed: 15929052
Cerebrovasc Dis. 2005;20(2):101-7
pubmed: 15976503
J Neurosurg. 2005 Jul;103(1):38-45
pubmed: 16121971
Neuroscience. 2006;137(2):393-9
pubmed: 16298076
Soc Sci Med. 1992 May;34(9):973-81
pubmed: 1631610
BMJ. 2006 May 6;332(7549):1061-4
pubmed: 16547014
Nature. 2006 Jun 29;441(7097):1094-6
pubmed: 16810245
Neurosurg Focus. 2008;24(3-4):E15
pubmed: 18341391
Stroke. 2009 Feb;40(2):510-5
pubmed: 19095993
Neurorehabil Neural Repair. 2009 Nov;23(9):895-909
pubmed: 19633272
Stem Cells Dev. 2010 Jan;19(1):5-16
pubmed: 19951197
Ann Intern Med. 2010 Jun 1;152(11):726-32
pubmed: 20335313
Stem Cells. 2010 Jun;28(6):1099-106
pubmed: 20506226
Stroke. 2010 Oct;41(10):2254-8
pubmed: 20829513
Can Fam Physician. 1992 Feb;38:381-8
pubmed: 21221264
Stroke. 2011 Mar;42(3):825-9
pubmed: 21273569
Ann Neurol. 2011 Jul;70(1):59-69
pubmed: 21786299
Br Med Bull. 2011;100:137-55
pubmed: 21852279
J Neurol Sci. 2012 Feb 15;313(1-2):1-6
pubmed: 22047648
Stem Cells Dev. 2012 Jul 20;21(11):1838-51
pubmed: 22074360
Tex Heart Inst J. 2011;38(5):474-85
pubmed: 22163120
Stem Cells. 2012 Apr;30(4):785-96
pubmed: 22213183
Int J Stroke. 2012 Oct;7(7):582-8
pubmed: 22687044
Stroke. 2012 Aug;43(8):2242-4
pubmed: 22764211
Indian J Med Res. 2012 Aug;136(2):221-8
pubmed: 22960888
Cell Transplant. 2013;22(6):977-91
pubmed: 23031629
PLoS One. 2012;7(10):e46842
pubmed: 23056481
Cell Transplant. 2013;22(9):1541-52
pubmed: 23067568
PLoS One. 2012;7(11):e50444
pubmed: 23185625
Cochrane Database Syst Rev. 2012 Dec 12;12:MR000033
pubmed: 23235689
Lancet. 2013 Jan 12;381(9861):91-2
pubmed: 23305999
Biol Blood Marrow Transplant. 2013 May;19(5):820-30
pubmed: 23416852
Int J Stroke. 2014 Apr;9(3):381-6
pubmed: 23692637
Trials. 2013 Oct 01;14:317
pubmed: 24083670
Stroke. 2014 Feb;45(2):634-9
pubmed: 24368562
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
Stroke. 2014 May;45(5):1545-88
pubmed: 24503673
J Comp Neurol. 2014 Sep 1;522(13):3120-37
pubmed: 24610730
Neuroradiology. 2014 Jun;56(6):467-76
pubmed: 24668181
Stem Cells Transl Med. 2014 Nov;3(11):1322-30
pubmed: 25107583
J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2694-700
pubmed: 25304723
Stroke. 2014 Dec;45(12):3618-24
pubmed: 25378424
Int J Stem Cells. 2014 Nov;7(2):63-9
pubmed: 25473443
Cytotherapy. 2015 Jun;17(6):775-785
pubmed: 25800775
J Neurol Sci. 2015 May 15;352(1-2):1-11
pubmed: 25818674
BMJ Open. 2015 Apr 13;5(4):e006648
pubmed: 25869683
Int J Stroke. 2015 Oct;10(7):1149-52
pubmed: 26044701
Med Sci Monit. 2015 Jul 28;21:2190-5
pubmed: 26215395
Transl Stroke Res. 2015 Dec;6(6):421-9
pubmed: 26482176
J Clin Neurol. 2016 Jan;12(1):14-20
pubmed: 26610894
Lancet Neurol. 2016 Feb;15(2):219-230
pubmed: 26704439
Clin Trials. 2016 Apr;13(2):117-26
pubmed: 26908540
Neural Regen Res. 2016 Feb;11(2):298-304
pubmed: 27073384
Perspect Clin Res. 2016 Apr-Jun;7(2):62-7
pubmed: 27141471
Stroke. 2016 Jul;47(7):1817-24
pubmed: 27256670
Transl Stroke Res. 2016 Oct;7(5):378-87
pubmed: 27384771
Lancet. 2016 Aug 20;388(10046):787-96
pubmed: 27497862
Lancet. 2016 Aug 20;388(10046):736-8
pubmed: 27497863
Transl Stroke Res. 2016 Dec;7(6):452-457
pubmed: 27515852
Regen Med. 2016 Oct;11(7):725-41
pubmed: 27580670
Cell Stem Cell. 2016 Sep 1;19(3):293-7
pubmed: 27588746
J Stroke. 2016 Sep;18(3):256-266
pubmed: 27733032
Mol Ther. 2016 Oct;24(10):1710-1711
pubmed: 27818493
Front Neurol. 2016 Dec 16;7:228
pubmed: 28018286
Transl Stroke Res. 2017 Apr;8(2):93-103
pubmed: 28127687
Lancet Neurol. 2017 May;16(5):360-368
pubmed: 28320635
Stem Cell Reports. 2017 May 9;8(5):1190-1201
pubmed: 28416287
Stem Cell Res Ther. 2017 Aug 30;8(1):191
pubmed: 28854961
Stroke Vasc Neurol. 2017 May 22;2(2):59-64
pubmed: 28959493
BMJ Open. 2017 Oct 5;7(10):e015997
pubmed: 28982811
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Int J Stroke. 2018 Jun;13(4):444-448
pubmed: 29134924
Eur J Vasc Endovasc Surg. 2018 Feb;55(2):257-265
pubmed: 29208350
Curr Neurol Neurosci Rep. 2018 Jan 25;18(1):1
pubmed: 29372464
Stroke. 2018 Mar;49(3):700-709
pubmed: 29382802
Stem Cells Transl Med. 2018 Jul;7(7):521-529
pubmed: 29752869
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
Cell Stem Cell. 2018 Jun 01;22(6):824-833
pubmed: 29859173
Front Neurol. 2018 Jun 07;9:198
pubmed: 29930530
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD78-AMD82
pubmed: 30025109
Neural Regen Res. 2018 Jul;13(7):1294-1304
pubmed: 30028342
Stem Cell Res Ther. 2018 Aug 24;9(1):228
pubmed: 30143053
Intensive Care Med. 2018 Oct;44(10):1613-1627
pubmed: 30151688
Stem Cells Transl Med. 2019 Jan;8(1):14-21
pubmed: 30156755
J Neurosurg. 2018 Nov 1;:1-11
pubmed: 30497166

Auteurs

Mirja Krause (M)

The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
Department of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.

Thanh G Phan (TG)

Department of Medicine, Monash University, Melbourne, VIC, Australia.

Henry Ma (H)

Department of Medicine, Monash University, Melbourne, VIC, Australia.

Christopher G Sobey (CG)

Department of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne, VIC, Australia.

Rebecca Lim (R)

The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia.
Department of Obstetrics and Gynaecology, Monash University, Melbourne, VIC, Australia.
Australian Regenerative Medicine Institute, Monash University, Melbourne, VIC, Australia.

Classifications MeSH